116 related articles for article (PubMed ID: 36726335)
1. The relationship between connexin-43 expression and Ki67 in non-glial central nervous system tumors.
Krigers A; Moser P; Fritsch H; Demetz M; Kerschbaumer J; Brawanski KR; Thomé C; Freyschlag CF
Int J Biol Markers; 2023 Mar; 38(1):46-52. PubMed ID: 36726335
[TBL] [Abstract][Full Text] [Related]
2. Potential doubling time and tumour doubling time in meningiomas and neurinomas.
Nakasu S; Nakasu Y; Nakajima M; Yokoyama M; Matsuda M; Handa J
Acta Neurochir (Wien); 1996; 138(6):763-70. PubMed ID: 8836295
[TBL] [Abstract][Full Text] [Related]
3. [Differential immunohistochemical characteristics of meningiomas and other neoplasms of the central nervous system].
Pérez-Bacete MJ; Cerdá-Nicolás M; Piquer J; Peydró-Olaya A
Arch Neurobiol (Madr); 1989; 52(6):265-72. PubMed ID: 2635847
[TBL] [Abstract][Full Text] [Related]
4. [An autopsy case of intracranial multiple meningiomas associated with extracranial multiple neurinomas].
Watanabe M; Watanabe Z; Sasaki T; Yamao N; Tanji H; Kodama N; Sato Y; Honda T; Endo S
No Shinkei Geka; 1984 Jul; 12(8):995-9. PubMed ID: 6435004
[TBL] [Abstract][Full Text] [Related]
5. [Cell kinetics of human meningiomas and neurinomas--Ki-67 PAP stain].
Shibata T; Burger PC; Kleihues P
No Shinkei Geka; 1988 Jul; 16(8):939-44. PubMed ID: 3050583
[TBL] [Abstract][Full Text] [Related]
6. DNA topoisomerase IIalpha expression correlates with cell proliferation but not with recurrence in intracranial meningiomas.
Konstantinidou AE; Patsouris E; Korkolopoulou P; Kavantzas N; Mahera H; Davaris P
Histopathology; 2001 Oct; 39(4):402-8. PubMed ID: 11683942
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical and ultrastructural study of gap junction proteins connexin26 and 43 in human arachnoid villi and meningeal tumors.
Arishima H; Sato K; Kubota T
J Neuropathol Exp Neurol; 2002 Dec; 61(12):1048-55. PubMed ID: 12484567
[TBL] [Abstract][Full Text] [Related]
8. [Expression of HER2/neu in meningiomas: an immunohistochemistry and fluorescence in situ hybridization study].
Wang CL; Mei JH; Wang SS; Xu S; Xu LL; Xiong YF
Zhonghua Bing Li Xue Za Zhi; 2010 Mar; 39(3):156-60. PubMed ID: 20450760
[TBL] [Abstract][Full Text] [Related]
9. Expression of cell adhesion proteins and proteins related to angiogenesis and fatty acid metabolism in benign, atypical, and anaplastic meningiomas.
Panagopoulos AT; Lancellotti CL; Veiga JC; de Aguiar PH; Colquhoun A
J Neurooncol; 2008 Aug; 89(1):73-87. PubMed ID: 18418552
[TBL] [Abstract][Full Text] [Related]
10. Expression of progestrone receptor and proliferative marker ki 67 in various grades of meningioma.
Shayanfar N; Mashayekh M; Mohammadpour M
Acta Med Iran; 2010; 48(3):142-7. PubMed ID: 21137648
[TBL] [Abstract][Full Text] [Related]
11. Reduced expression of the P2 form of the gap junction protein connexin43 in malignant meningiomas.
Sato K; Gratas C; Lampe J; Biernat W; Kleihues P; Yamasaki H; Ohgaki H
J Neuropathol Exp Neurol; 1997 Jul; 56(7):835-9. PubMed ID: 9210880
[TBL] [Abstract][Full Text] [Related]
12. Intracranial meningiomas, the VEGF-A pathway, and peritumoral brain oedema.
Nassehi D
Dan Med J; 2013 Apr; 60(4):B4626. PubMed ID: 23651727
[TBL] [Abstract][Full Text] [Related]
13. Meningiomas: correlation of Ki67 with histological grade.
Babu S; Uppin SG; Uppin MS; Panigrahi MK; Saradhi V; Bhattacharjee S; Sahu BP; Purohit AK; Challa S
Neurol India; 2011; 59(2):204-7. PubMed ID: 21483118
[TBL] [Abstract][Full Text] [Related]
14. CD90 expression in atypical meningiomas and meningioma metastasis.
Scognamiglio G; D'Antonio A; Rossi G; Cavazza A; Camerlingo R; Pirozzi G; La Mantia E; Anniciello AM; Morabito A; Cantile M; Boscaino A; Sparano L; Botti G; Rocco G; Franco R
Am J Clin Pathol; 2014 Jun; 141(6):841-9. PubMed ID: 24838329
[TBL] [Abstract][Full Text] [Related]
15. Cyclin D1 immunoreactivity in meningiomas.
Milenković S; Marinkovic T; Jovanovic MB; Djuricic S; Berisavac II; Berisavac I
Cell Mol Neurobiol; 2008 Sep; 28(6):907-13. PubMed ID: 18379871
[TBL] [Abstract][Full Text] [Related]
16. Assessment of expression of epidermal growth factor receptor and p53 in meningiomas.
Narla S; Uppin MS; Saradhi MV; Sahu BP; Purohit AK; Sundaram C
Neurol India; 2014; 62(1):37-41. PubMed ID: 24608452
[TBL] [Abstract][Full Text] [Related]
17. WHO grade, proliferation index, and progesterone receptor expression are different according to the location of meningioma.
Maiuri F; Mariniello G; Guadagno E; Barbato M; Corvino S; Del Basso De Caro M
Acta Neurochir (Wien); 2019 Dec; 161(12):2553-2561. PubMed ID: 31637512
[TBL] [Abstract][Full Text] [Related]
18. PTTG-1 (Securin) immunoexpression in meningiomas correlates with tumor grade and proliferation rate: potential use as a diagnostic marker of malignancy.
Iliadis A; Virvili MA; Flaris NA; Pervana S; Pazarli E; Tripsianis G; Grigoriou ME; Efstratiou I; Kanakis DN
APMIS; 2018 Apr; 126(4):295-302. PubMed ID: 29575197
[TBL] [Abstract][Full Text] [Related]
19. Periostin: a novel prognostic predictor for meningiomas.
Liu Y; Shi J; Chen M; Cao YF; Liu YW; Pan J; Qi ST
J Neurooncol; 2015 Feb; 121(3):505-12. PubMed ID: 25519301
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical expression of SPARC is correlated with recurrence, survival and malignant potential in meningiomas.
Bozkurt SU; Ayan E; Bolukbasi F; Elmaci I; Pamir N; Sav A
APMIS; 2009 Sep; 117(9):651-9. PubMed ID: 19703125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
